Drug
Perfluorohexyloctane
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Product Use Complaint | 144 | 102.7 | 111.0 | signal |
| 2 | Exposure Via Skin Contact | 118 | 57.5 | 61.2 | signal |
| 3 | Product Packaging Quantity Issue | 55 | 55.5 | 57.1 | signal |
| 4 | Eye Discharge | 51 | 55.0 | 56.4 | signal |
| 5 | Ocular Discomfort | 50 | 50.7 | 52.0 | signal |
| 6 | Product Complaint | 109 | 48.1 | 50.9 | signal |
| 7 | Eye Irritation | 241 | 47.6 | 54.3 | signal |
| 8 | Circumstance Or Information Capable Of Leading To Medication Error | 142 | 46.6 | 50.2 | signal |
| 9 | Eye Pain | 231 | 46.0 | 52.2 | signal |
| 10 | Inability To Afford Medication | 31 | 34.6 | 35.2 | signal |
| 11 | Prescribed Underdose | 59 | 32.5 | 33.5 | signal |
| 12 | Ocular Hyperaemia | 131 | 30.8 | 33.0 | signal |
| 13 | Lacrimation Increased | 77 | 28.3 | 29.4 | signal |
| 14 | Dry Eye | 121 | 27.4 | 29.2 | signal |
| 15 | Photophobia | 41 | 24.1 | 24.6 | signal |
| 16 | Vision Blurred | 239 | 19.2 | 21.8 | signal |
| 17 | Inappropriate Schedule Of Product Administration | 265 | 16.4 | 18.9 | signal |
| 18 | Product Dose Omission In Error | 38 | 15.5 | 15.8 | signal |
| 19 | Eye Pruritus | 43 | 14.3 | 14.6 | signal |
| 20 | Accidental Exposure To Product | 118 | 13.0 | 13.7 | signal |
| 21 | Eye Swelling | 43 | 12.8 | 13.0 | signal |
| 22 | Intentional Product Use Issue | 96 | 12.0 | 12.5 | signal |
| 23 | Poor Quality Product Administered | 11 | 11.8 | 11.9 | signal |
| 24 | Burning Sensation | 73 | 11.4 | 11.8 | signal |
| 25 | Insurance Issue | 15 | 11.1 | 11.2 | signal |
| 26 | Product Use Issue | 186 | 10.9 | 12.0 | signal |
| 27 | Eye Infection | 11 | 10.8 | 10.8 | signal |
| 28 | Eye Inflammation | 9 | 10.5 | 10.5 | signal |
| 29 | Product Prescribing Issue | 19 | 10.2 | 10.3 | signal |
| 30 | Eye Disorder | 30 | 10.0 | 10.2 | signal |
| 31 | Eye Haemorrhage | 11 | 9.0 | 9.1 | signal |
| 32 | Therapy Interrupted | 53 | 8.4 | 8.6 | signal |
| 33 | Vitreous Floaters | 7 | 7.9 | 7.9 | signal |
| 34 | Product Availability Issue | 16 | 7.8 | 7.9 | signal |
| 35 | Intraocular Pressure Increased | 8 | 6.8 | 6.9 | signal |
| 36 | Glaucoma | 12 | 6.8 | 6.9 | signal |
| 37 | Visual Impairment | 76 | 6.8 | 7.0 | signal |
| 38 | Product Packaging Issue | 5 | 5.9 | 5.9 | signal |
| 39 | Dermatitis Contact | 6 | 5.8 | 5.8 | signal |
| 40 | Autoimmune Disorder | 5 | 5.7 | 5.7 | signal |
| 41 | Surgery | 30 | 5.7 | 5.7 | signal |
| 42 | Product Administration Error | 10 | 5.5 | 5.5 | signal |
| 43 | Brain Fog | 7 | 5.3 | 5.3 | signal |
| 44 | Blindness Unilateral | 6 | 4.7 | 4.7 | signal |
| 45 | Product Odour Abnormal | 4 | 4.2 | 4.2 | signal |
| 46 | Wrong Technique In Product Usage Process | 77 | 4.2 | 4.3 | signal |
| 47 | Intentional Dose Omission | 10 | 4.0 | 4.0 | signal |
| 48 | Drug Effect Less Than Expected | 5 | 3.9 | 3.9 | signal |
| 49 | Product Prescribing Error | 8 | 3.7 | 3.7 | signal |
| 50 | Uveitis | 4 | 3.2 | 3.2 | signal |
| 51 | Product Storage Error | 22 | 2.8 | 2.8 | signal |
| 52 | Expired Product Administered | 8 | 2.6 | 2.6 | signal |
| 53 | Product Quality Issue | 31 | 2.5 | 2.5 | signal |
| 54 | Extra Dose Administered | 9 | 2.5 | 2.5 | signal |
| 55 | Therapeutic Response Shortened | 5 | 1.7 | 1.7 | no signal |
| 56 | Dermatitis Atopic | 5 | 1.1 | 1.1 | no signal |